Dariusz Onichimowski Krzysztof Nosek Radosław Goraj Rakesh Jalali Aleksandra Wińska Aleksandra Pawlos Bułat Tuyakov
10.2147/DDDT.S158237
Drug Des Devel Ther
2018 Jun 20;12:1777-1783.
cerebral arterial aneurysm cerebral vasospasm levosimendan subarachnoid hemorrhage
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/29950812/
Cerebral Arteries / drug effects Hydrazones / therapeutic use Pyridazines / therapeutic use Subarachnoid Hemorrhage / drug therapy Vasoconstriction / drug effects Vasodilator Agents / therapeutic use Vasospasm, Intracranial / drug therapy
Cerebral Arteries / drug effects Hydrazones / therapeutic use Pyridazines / therapeutic use Subarachnoid Hemorrhage / drug therapy Vasoconstriction / drug effects Vasodilator Agents / therapeutic use Vasospasm, Intracranial / drug therapy Case Reports Cerebral Angiography / methods Cerebral Arteries / diagnostic imaging Cerebral Arteries / physiopathology Computed Tomography Angiography Female Humans Hydrazones / adverse effects Middle Aged Pyridazines / adverse effects Simendan Subarachnoid Hemorrhage / diagnostic imaging Subarachnoid Hemorrhage / physiopathology Treatment Outcome Vasodilator Agents / adverse effects Vasospasm, Intracranial / diagnostic imaging Vasospasm, Intracranial / physiopathology Hydrazones Pyridazines Vasodilator Agents Simendan
PMC6018894
29950812
Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study
2018